Ayman Shehata Dawood
Tanta, Algharbia, 31111, Egypt
NCT Number: NCT03898934
To assess whether Vitamin D supplementations for patients with polycystic ovary syndrome in conjunction with clomiphene citrate are beneficial or not
Looking for future studies?
Notify Me20 year–35 year
Female
Interventional
Phase 4
Tanta, Algharbia, 31111, Egypt
This study is double blinded randomized controlled study conducted at Tanta University hospitals in the period from April 2019 to March 2022. Patients and methods: One hundred twelve patients were recruited and randomly allocated into 2 groups; study group with Vitamin D supplementation and control group without Vitamin D supplementation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
receive 6000iu daily for 8 weeks
placebo for the same period
Time frame: 3 months
Number of mature follicles obtained
Time frame: 3 months
Number of patients who get pregnant
Tanta University
Other
Dose Vitamin-D Supplementation Affect Reproductive Outcomes in Patients With Polycystic Ovary Syndrome?
Acronym: PCOvit-D
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07513480
PCOS
Dhaka, Shahbag, Bangladesh
View Trial DetailsNCT06530498
Adnexal Diseases, Alopecia
Krakow, Poland
View Trial DetailsNCT03919929
Adolescent Obesity, Body Weight
Aurora, Colorado, United States
View Trial DetailsNCT05971849
Adnexal Diseases, Cysts
Boston, Massachusetts, United States
View Trial Details